Fusobacterium, a common mouth bacteria, appears to have the ability to kill certain cancers. Lab studies found 70%-99% reduction in number of viable head and neck cancer cells after being infected with it. When detected in head and neck cancers it is associated with a 65% reduction in risk of death.
Read Full Article
#Fusobacterium #CancerTreatment #OralMicrobiome #HeadAndNeckCancer #MedicalResearch
Read Full Article
#Fusobacterium #CancerTreatment #OralMicrobiome #HeadAndNeckCancer #MedicalResearch
the Guardian
Type of mouth bacteria ‘melts’ some cancers, study finds
People with head and neck cancers are said to have better outcomes if fusobacterium is found with their cancer
🤯2👏1
People who use marijuana at high levels are putting themselves at more than three times the risk for head and neck cancers. The study is perhaps the most rigorous ever conducted on the issue, tracking the medical records of over 4 million U.S. adults for 20 years.
Read Full Article
#marijuanarisk #headandneckcancer #medicalresearch #cannabisstudy #healthnews
Read Full Article
#marijuanarisk #headandneckcancer #medicalresearch #cannabisstudy #healthnews
Jamanetwork
Cannabis Use and Head and Neck Cancer
This cohort study examines the clinical association between cannabis use and head and neck cancer.
👍3
Bacteria inside tumors suppress the immune response, driving immunotherapy resistance. Head and neck cancer patients with high tumor bacteria levels had poorer outcomes with immunotherapy compared to standard chemoradiotherapy. 🦠🦷💉🚑
Read Full Article
#TumorBacteria #ImmunotherapyResistance #HeadAndNeckCancer #CancerResearch #OncologyInsights
Read Full Article
#TumorBacteria #ImmunotherapyResistance #HeadAndNeckCancer #CancerResearch #OncologyInsights
Nature
Intratumoral bacteria are immunosuppressive and promote immunotherapy resistance in head and neck squamous cell carcinoma
Nature Cancer - McGrail and colleagues report that high intratumoral bacteria abundance is associated with an immunosuppressive microenvironment and resistance to immune checkpoint blockade in head...
👍1👀1
Ultrasensitive Blood Test Predicts Recurrence and Survival After Treatment for Head and Neck Cancer
Read Full Article
#HeadAndNeckCancer #LiquidBiopsy #CancerRecurrenceSurvival
Read Full Article
#HeadAndNeckCancer #LiquidBiopsy #CancerRecurrenceSurvival
Mass General Brigham
Ultrasensitive Blood Test Predicts Recurrence and Survival After Treatment for Head and Neck Cancer
HPV-DeepSeek shows promise for more personalized post-operative treatment plans by identifying patients who may benefit from additional treatment.
Science News
Ultrasensitive Blood Test Predicts Recurrence and Survival After Treatment for Head and Neck Cancer Read Full Article #HeadAndNeckCancer #LiquidBiopsy #CancerRecurrenceSurvival
🔬 New study from Mass General Brigham Cancer Institute shows HPV-DeepSeek blood test can identify patients with HPV-associated head and neck cancer who may need further treatment after surgery.
📊 The Clear-HPVca study followed 103 patients between August 2020 and March 2024. After surgery, 23% had detectable circulating tumor HPV DNA, and these patients had significantly worse outcomes, with only 60% disease-free at two years compared to 100% of those with negative tests.
⏱️ HPV-DeepSeek detected cancer recurrence an average of seven months earlier than traditional methods and existing HPV DNA blood tests, potentially offering a longer lead time for intervention.
💡 Researchers believe this ultrasensitive test could lead to more personalized treatment plans, moving beyond general risk factors to tailor care based on individual cancer biology.
#CancerResearch #HeadAndNeckCancer #PrecisionMedicine
📊 The Clear-HPVca study followed 103 patients between August 2020 and March 2024. After surgery, 23% had detectable circulating tumor HPV DNA, and these patients had significantly worse outcomes, with only 60% disease-free at two years compared to 100% of those with negative tests.
⏱️ HPV-DeepSeek detected cancer recurrence an average of seven months earlier than traditional methods and existing HPV DNA blood tests, potentially offering a longer lead time for intervention.
💡 Researchers believe this ultrasensitive test could lead to more personalized treatment plans, moving beyond general risk factors to tailor care based on individual cancer biology.
#CancerResearch #HeadAndNeckCancer #PrecisionMedicine
People vaccinated against HPV have lower risk of head and neck cancer, study suggests
Read Full Article
#HPV #HeadAndNeckCancer #VaccinationBenefits
Read Full Article
#HPV #HeadAndNeckCancer #VaccinationBenefits
👏2❤1